posted on 2022-04-04, 10:41authored byFatemeh Zahedipour, Seyede Atefe Hosseini, Neil C. Henney, George E. Barreto, Amirhossein Sahebkar
Inflammatory processes and proinflammatory cytokines have a key role in the cellular
processes of neurodegenerative diseases and are linked to the pathogenesis of functional
and mental health disorders. Tumor necrosis factor alpha has been reported to play a
major role in the central nervous system in Alzheimer’s disease, Parkinson’s disease and
amyotrophic lateral sclerosis and many other neurodegenerative diseases. Therefore,
a potent proinflammatory/proapoptotic tumor necrosis factor alpha could be a strong
candidate for targeted therapy. Plant derivatives have now become promising candidates
as therapeutic agents because of their antioxidant and chemical characteristics, and
anti-inflammatory features. Recently, phytochemicals including flavonoids, terpenoids,
alkaloids, and lignans have generated interest as tumor necrosis factor alpha inhibitor
candidates for a number of diseases involving inflammation within the nervous system. In
this review, we discuss how phytochemicals as tumor necrosis factor alpha inhibitors are a
therapeutic strategy targeting neurodegeneration.